Novan Inc (NOVN)

Novan (NOVN) Stock Price & Analysis


NOVN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.03 - $2.15
Previous Close$0.07
Average Volume (3M)3.21M
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$13.19M
Total Debt (Recent Filing)$3.85M
Price to Earnings (P/E)N/A
Nov 07, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding28,015,371
10 Day Avg. Volume4,960,510
30 Day Avg. Volume3,208,256
Standard Deviation0.34
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)0.88
Price to Cash Flow (P/CF)N/A
P/FCF Ratio4.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Novan Inc’s price range in the past 12 months?
Novan Inc lowest stock price was $0.03 and its highest was $2.15 in the past 12 months.
    What is Novan Inc’s market cap?
    Currently, no data Available
    When is Novan Inc’s upcoming earnings report date?
    Novan Inc’s upcoming earnings report date is Nov 07, 2023 which is in 35 days.
      How were Novan Inc’s earnings last quarter?
      Currently, no data Available
      Is Novan Inc overvalued?
      According to Wall Street analysts Novan Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Novan Inc pay dividends?
        Novan Inc does not currently pay dividends.
        What is Novan Inc’s EPS estimate?
        Novan Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Novan Inc have?
        Currently, no data Available
        What happened to Novan Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Novan Inc?
        Currently, no hedge funds are holding shares in NOVN


        Novan Stock Smart Score

        This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
        Learn more about TipRanks Smart Score

        Company Description

        Novan Inc

        Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.


        Forecast EPS vs Actual EPS

        Currently, no data available
        Please return soon. This page is being updated.

        Similar Stocks
        Price & Change
        Viveve Medical
        Corcept Therapeutics

        Popular Stocks

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis